RUA Life Sciences (LON:RUA) Issues Earnings Results

RUA Life Sciences (LON:RUA) posted its earnings results on Tuesday. The company reported GBX (0.33) earnings per share for the quarter, Digital Look Earnings reports. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%.

RUA Life Sciences Price Performance

Shares of RUA stock traded up GBX 0.88 during trading hours on Thursday, hitting GBX 19.88. The company had a trading volume of 100 shares, compared to its average volume of 240,354. RUA Life Sciences has a 12 month low of GBX 10.42 and a 12 month high of GBX 26.80. The firm has a market capitalization of £12.34 million, a price-to-earnings ratio of -2.61 and a beta of 0.96. The firm’s fifty day moving average is GBX 19.96 and its 200 day moving average is GBX 16. The company has a debt-to-equity ratio of 18.95, a quick ratio of 7.32 and a current ratio of 4.64.

About RUA Life Sciences

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.